Form D · Pharmaceuticals
OWP PHARMACEUTICALS, INC.
Lisle, IL · CIK 0002037010
Offering snapshot reported Sep 9, 2025 · SEC filing
- Reported sold
- $2.41M Offering amount: $2.41M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Jul 25, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2025 | Initial | $2,405,000 | No comparison | 19 | SEC filing |
| Sep 16, 2024 | Initial | $2,730,773 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-557097
Source: Form D, filed Sep 9, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steve Bourne | Executive |
| Scott Boyer | Director, Executive |
| Bruce Duncan | Director |
| Kurt Florian | Director |
| Carol Gavin | Director |
| Troy Hammond | Director |
| Matt Litfin | Director |
| Paul Regan | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
701 Warrenville Road Suite 200
Lisle, IL, 60532
Phone: 847-722-0803
Lisle, IL, 60532
Phone: 847-722-0803